News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Acorda Announces EMA Validation of the MAA Submission for INBRIJA™

(May 29, 2018) - Acorda Therapeutics, Inc today announced that the European Medicines Agency (EMA) has completed formal validation of Acorda’s Marketing Authorization Application (MAA) for INBRIJA. INBRIJA is an investigational inhaled levodopa treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen. Read more